Dr Alice Halliday received her BSc in Microbiology from the University of Manchester in 2008. She subsequently worked as a research assistant on an NHS-funded project exploring health care needs in relation to immunisation uptake in Manchester. She then moved back to laboratory science, gaining a PhD from the Liverpool School of Tropical Medicine (LSTM) exploring the immune responses to Leishmania infection. Her first postdoc, also at LSTM, involved the development of models of Onchocerciasis for drug screening, both in the UK and in Cameroon.
In 2014, Dr Halliday moved to Imperial College where her work has been focused on exploring cellular immune responses in Tuberculosis, with a particular interest in the development of new diagnostic tools.
et al., 2016, The TLR2/6 ligand PAM2CSK4 is a Th2 polarizing adjuvant in Leishmania major and Brugia malayi murine vaccine models., Parasit Vectors, Vol:9
et al., 2014, A murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasis., Parasit Vectors, Vol:7
et al., 2011, Onchocerciasis: the role of Wolbachia bacterial endosymbionts in parasite biology, disease pathogenesis, and treatment., Clin Microbiol Rev, Vol:24, Pages:459-468
et al., 2010, The effect of placental malaria infection on cord blood and maternal immunoregulatory responses at birth, European Journal of Immunology, Vol:40, ISSN:0014-2980, Pages:1062-1072